Litcius/Paper detail

Effects of Sirolimus on Anti-SARS-CoV-2 Vaccination in Patients With Lymphangioleiomyomatosis

Tatyana Worthy, Amanda Jones, Bennett Yang, Hiroko Ishiwata-Endo, Nishant Gupta, Joel Moss

2023CHEST Journal17 citationsDOIOpen Access PDF

Topics & Concepts

LymphangioleiomyomatosisTuberous sclerosisMedicineSirolimusTSC2AngiomyolipomaLymphatic systemPI3K/AKT/mTOR pathwayLungTSC1Cancer researchLymphangiomatosisPathologyImmunologyInternal medicineSignal transductionKidneyGeneticsBiologyTuberous Sclerosis Complex ResearchPolyomavirus and related diseasesInterstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Effects of Sirolimus on Anti-SARS-CoV-2 Vaccination in Patients With Lymphangioleiomyomatosis | Litcius